Get started
Author

Doriana Landi

Observed names: D Landi, D. Landi, Landi, Doriana, Riccardo Orlandi
Observed institutions: University of Rome Tor Vergata, University of Verona, Marche Polytechnic University, Università Campus Bio-Medico, University of Campania "Luigi Vanvitelli", Istituto Neurologico Mediterraneo, Fondazione G.B. Bietti, Fatebenefratelli Hospital, Federico II University Hospital, Policlinico Tor Vergata, Campus Bio Medico University Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Institute of Cognitive Sciences and Technologies, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, University of Turin, University of Naples Federico II, University of Genoa, Sapienza University of Rome, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0002-3309-8417
Observed ORCID: 0000-0002-3309-8417
OpenAlex ID: A5040947413
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
2021 · Maria Pia Sormani, Maria Pia Sormani, et al. · EBioMedicine · 228
PDF
Cognition is related to resting-state small-world network topology: an magnetoencephalographic study
2010 · L. Douw, M.M. Schoonheim, et al. · Neuroscience · 147
PDF
Functional connectivity changes in multiple sclerosis patients: A graph analytical study of MEG resting state data
2011 · Menno M. Schoonheim, Jeroen J.G. Geurts, et al. · Human Brain Mapping · 115
Sex effects across the lifespan in women with multiple sclerosis
2020 · Kristen M. Krysko, Jennifer S. Graves, et al. · Therapeutic Advances in Neurological Disorders · 105
PDF
Gender-related differences in functional connectivity in multiple sclerosis
2011 · Menno M Schoonheim, Hanneke E Hulst, et al. · Multiple Sclerosis Journal · 102
Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
2017 · S. Migliore, A. Ghazaryan, et al. · Behavioural Neurology · 94
PDF
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
2016 · Maria Albanese, Sara Zagaglia, et al. · Journal of Neuroinflammation · 88
PDF
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
2022 · Maria Pia Sormani, Irene Schiavetti, et al. · EBioMedicine · 87
PDF
COVID-19: dealing with a potential risk factor for chronic neurological disorders
2020 · Tommaso Schirinzi, Doriana Landi, et al. · Journal of Neurology · 77
PDF
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML
2017 · Doriana Landi, Nicola De Rossi, et al. · Neurology · 73
PDF
COVID-19 Severity in Multiple Sclerosis
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Neurology Neuroimmunology & Neuroinflammation · 70
PDF
Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability
2019 · Mariacristina Siotto, Maria Maddalena Filippi, et al. · Frontiers in Neuroscience · 64
PDF
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment
2013 · Paola Maggio, Claudia Altamura, et al. · Journal of the Neurological Sciences · 57
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
2019 · Marinella Clerico, Stefania Federica De Mercanti, et al. · Neurotherapeutics · 56
PDF
Cortico-muscular coherence as an index of fatigue in multiple sclerosis
2012 · L Tomasevic, G Zito, et al. · Multiple Sclerosis Journal · 54
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course
2018 · Mario Stampanoni Bassi, Ennio Iezzi, et al. · Journal of Neurology · 48
Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach
2008 · Franca Tecchio, Giancarlo Zito, et al. · Brain · 48
PDF
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 46
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
2022 · Maria Petracca, Serena Ruggieri, et al. · Neurology and Therapy · 44
PDF
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing–remitting multiple sclerosis
2014 · D. Landi, S. Vollaro, et al. · Clinical Neurophysiology · 43
Thalamocortical sensorimotor circuit in multiple sclerosis: An integrated structural and electrophysiological assessment
2010 · Maria Luisa Dell'Acqua, Doriana Landi, et al. · Human Brain Mapping · 43
Cladribine vs other drugs in MS
2020 · Alessio Signori, Francesco Saccà, et al. · Neurology Neuroimmunology & Neuroinflammation · 42
PDF
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
2022 · Marco Iannetta, Doriana Landi, et al. · Frontiers in Immunology · 40
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
2018 · Massimiliano Mirabella, Luca Prosperini, et al. · CNS Drugs · 37
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
2019 · Giovanni Novi, Francesca Bovis, et al. · Multiple Sclerosis and Related Disorders · 35
Works count: 141
Citation count: 3,162
H-index: 33
I10-index: 63
Year
Topic
Type